クオリプスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/10/04 | 1,525 | 1,642 | 1,525 | 1,560 | -5 | -0.3% | 320,800 |
2023/10/03 | 1,662 | 1,664 | 1,544 | 1,565 | -111 | -6.6% | 289,600 |
2023/10/02 | 1,749 | 1,783 | 1,662 | 1,676 | -60 | -3.5% | 232,000 |
2023/09/29 | 1,746 | 1,764 | 1,726 | 1,736 | -10 | -0.6% | 111,200 |
2023/09/28 | 1,758 | 1,802 | 1,741 | 1,746 | -44 | -2.5% | 111,200 |
2023/09/27 | 1,777 | 1,820 | 1,755 | 1,790 | -10 | -0.6% | 109,900 |
2023/09/26 | 1,820 | 1,935 | 1,788 | 1,800 | -48 | -2.6% | 239,300 |
2023/09/25 | 2,097 | 2,097 | 1,837 | 1,848 | -80 | -4.1% | 347,000 |
2023/09/22 | 1,886 | 1,951 | 1,882 | 1,928 | +15 | +0.8% | 86,200 |
2023/09/21 | 1,950 | 1,955 | 1,888 | 1,913 | -52 | -2.6% | 124,700 |
2023/09/20 | 1,981 | 2,023 | 1,965 | 1,965 | -39 | -1.9% | 93,700 |
2023/09/19 | 2,028 | 2,045 | 1,972 | 2,004 | -41 | -2% | 159,100 |
2023/09/15 | 2,076 | 2,094 | 2,026 | 2,045 | -46 | -2.2% | 152,600 |
2023/09/14 | 2,200 | 2,212 | 2,020 | 2,091 | -21 | -1% | 190,800 |
2023/09/13 | 2,120 | 2,188 | 2,087 | 2,112 | +26 | +1.2% | 181,000 |
2023/09/12 | 2,069 | 2,163 | 2,055 | 2,086 | -4 | -0.2% | 183,200 |
2023/09/11 | 2,221 | 2,246 | 2,084 | 2,090 | -158 | -7% | 219,100 |
2023/09/08 | 2,240 | 2,262 | 2,178 | 2,248 | +4 | +0.2% | 121,700 |
2023/09/07 | 2,422 | 2,440 | 2,200 | 2,244 | -207 | -8.4% | 428,300 |
2023/09/06 | 2,455 | 2,527 | 2,405 | 2,451 | +1 | ±0% | 247,400 |
2023/09/05 | 2,279 | 2,450 | 2,270 | 2,450 | +158 | +6.9% | 249,100 |
2023/09/04 | 2,250 | 2,325 | 2,153 | 2,292 | -52 | -2.2% | 335,200 |
2023/09/01 | 2,497 | 2,520 | 2,322 | 2,344 | -153 | -6.1% | 452,700 |
2023/08/31 | 2,495 | 2,631 | 2,420 | 2,497 | +32 | +1.3% | 905,800 |
2023/08/30 | 2,460 | 2,597 | 2,324 | 2,465 | +29 | +1.2% | 1,035,700 |
2023/08/29 | 2,290 | 2,453 | 2,210 | 2,436 | +191 | +8.5% | 621,000 |
2023/08/28 | 2,105 | 2,279 | 2,088 | 2,245 | +155 | +7.4% | 441,300 |
2023/08/25 | 2,088 | 2,146 | 2,035 | 2,090 | +34 | +1.7% | 250,000 |
2023/08/24 | 1,917 | 2,064 | 1,903 | 2,056 | +122 | +6.3% | 229,500 |
2023/08/23 | 1,933 | 1,970 | 1,880 | 1,934 | +13 | +0.7% | 173,400 |
2023/08/22 | 1,817 | 1,935 | 1,784 | 1,921 | +139 | +7.8% | 195,300 |
2023/08/21 | 1,800 | 1,850 | 1,780 | 1,782 | -44 | -2.4% | 64,100 |
2023/08/18 | 1,788 | 1,848 | 1,756 | 1,826 | +20 | +1.1% | 83,700 |
2023/08/17 | 1,780 | 1,819 | 1,724 | 1,806 | +2 | +0.1% | 75,000 |
2023/08/16 | 1,670 | 1,807 | 1,670 | 1,804 | +104 | +6.1% | 128,300 |
2023/08/15 | 1,682 | 1,722 | 1,673 | 1,700 | +18 | +1.1% | 62,300 |
2023/08/14 | 1,704 | 1,760 | 1,638 | 1,682 | -22 | -1.3% | 103,500 |
2023/08/10 | 1,712 | 1,726 | 1,672 | 1,704 | -7 | -0.4% | 65,300 |
2023/08/09 | 1,750 | 1,750 | 1,704 | 1,711 | -40 | -2.3% | 62,000 |
2023/08/08 | 1,804 | 1,819 | 1,738 | 1,751 | -53 | -2.9% | 78,300 |
2023/08/07 | 1,802 | 1,863 | 1,755 | 1,804 | -11 | -0.6% | 68,300 |
2023/08/04 | 1,836 | 1,882 | 1,796 | 1,815 | -32 | -1.7% | 77,400 |
2023/08/03 | 1,815 | 1,895 | 1,782 | 1,847 | +31 | +1.7% | 116,200 |
2023/08/02 | 1,809 | 1,838 | 1,780 | 1,816 | -49 | -2.6% | 73,000 |
2023/08/01 | 1,790 | 1,887 | 1,772 | 1,865 | +69 | +3.8% | 144,800 |
2023/07/31 | 1,798 | 1,836 | 1,766 | 1,796 | +6 | +0.3% | 104,300 |
2023/07/28 | 1,840 | 1,846 | 1,730 | 1,790 | -51 | -2.8% | 274,000 |
2023/07/27 | 1,899 | 1,939 | 1,841 | 1,841 | -58 | -3.1% | 226,500 |
2023/07/26 | 1,974 | 1,985 | 1,871 | 1,899 | -75 | -3.8% | 316,700 |
2023/07/25 | 1,946 | 2,006 | 1,904 | 1,974 | +29 | +1.5% | 503,600 |
151~
200
件表示中 / 219件
類似銘柄と比較する
現在ご覧いただいている「クオリプス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
クオリプス | 323,000円 | -13.0% | - | 0.00% | - | 4.30倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
ステムリム | 46,500円 | -14.9% | -31.0% | 0.00% | 190.57倍 | 3.34倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
セルソース | 141,900円 | +19.0% | -13.1% | 0.35% | 39.09倍 | 4.57倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
扶桑薬 | 228,700円 | +2.9% | +23.1% | 3.50% | 11.50倍 | 0.53倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
大幸薬品 | 40,000円 | +11.1% | - | 0.00% | 36.50倍 | 2.98倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム